Filing Flows › National Health Investors (NHI) › Q2 2026 › vs Q2 2025
National Health Investors (NHI) Q2 2026 vs Q2 2025 (year over year)
National Health Investors's revenue rose $30.7M (+34%) from $90.7M in Q2 2025 to $121M in Q2 2026. Operating margin 46.2% against 40.5% (+5.8 pts).
National Health Investors, Q2 2026: revenue $121M (+34% year over year), operating margin 46.2%, net earnings $55.7M, operating cash flow $65.0M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Operating margin | 46.2% | 40.5% | +5.8 pts |
| Net margin | 45.9% | 40.8% | +5.1 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $121M | $90.7M | $30.7M | +34% |
| Operating profit | $56.1M | $36.7M | $19.4M | +53% |
| Costs & expenses | $65.2M | $54.0M | $11.3M | +21% |
| Pre-tax earnings | $56.1M | $36.7M | $19.4M | +53% |
| General & admin | $8.8M | $6.1M | $2.7M | +44% |
| Other operating costs | $56.4M | $47.8M | $8.6M | +18% |
| Loss borne by minority interests | $314K | $298K | $16K | +5% |
| Net earnings | $55.7M | $37.0M | $18.7M | +51% |
| Income tax | $732K | $0 | $732K | — |
| Depreciation & amortization | $25.5M | $19.9M | $5.6M | +28% |
| Share-based compensation | $2.4M | $1.1M | $1.3M | +120% |
| Working capital & other | $18.6M | −$1.8M | $20.4M | — |
| Operating cash flow | $65.0M | $59.8M | $5.2M | +9% |
Questions
How much did National Health Investors's revenue grow year over year in Q2 2026?
National Health Investors's revenue rose $30.7M (+34%) from $90.7M in Q2 2025 to $121M in Q2 2026. Operating margin 46.2% against 40.5% (+5.8 pts).